9-9:45am (Dr. Brugarolas)  Development of a first-in-class RCC Drug

10-10:45am (Dr. Arafat) Testicular Cancer II. 

Session date: 
05/29/2025 - 9:00am to 10:45am CDT
Location: 
In-person NC8.212 & Virtual Teams
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA
  • 1.75 Attendance
Please login or create an account to take this course.
Faculty List: 
Committee member(s)

Monika Kumar, MD

has no relevant financial relationships to disclose at this time.
Course Director(s)

Amy Jones, M.D.

has no relevant financial relationships to disclose at this time.
Peer reviewer(s)

Monika Kumar, MD

has no relevant financial relationships to disclose at this time.
Speaker(s)

Waddah Arafat

has no relevant financial relationships to disclose at this time.

James Brugarolas, Director, Kidney Cancer Program; Sherry Wigley Crow Endowed Chair in Cancer Research; Professor, Internal Medicine/ Hematology-Oncology, Cancer Biology, Genetics, Development and Disease

has a financial relationship (Professional Services) with Regeneron;.